Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000874015-14-000028
Filing Date
2014-01-24
Accepted
2014-01-24 20:26:07
Documents
1
Period of Report
2014-01-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 14007
  Complete submission text file 0000874015-14-000028.txt   15353
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
ISIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GENAISSANCE PHARMACEUTICALS INC FIVE SCIENCE PARK NEW HAVEN CT 06511
Business Address
KLEIN JOSEPH III (Reporting) CIK: 0001206369 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19125 | Film No.: 14547258